惠州市吸毒人群丙型肝炎感染现状研究  

A Research on the Current Infectious Situation of Hepatitis C among Drug Users in Huizhou

作　　者：徐志华[1] 琚雄飞[1] 方巧云[1] 

机构地区：[1]惠州市疾病预防控制中心,广东惠州516003

出　　处：《疾病监测与控制》2012年第5期260-261,共2页Journal of Diseases Monitor and Control

摘　　要：目的了解惠州市吸毒人群丙肝(HCV)感染现状,探讨吸毒人群传播丙肝的危险性,为控制丙肝的传播提供科学依据。方法应用酶联免疫吸附法(ELISA)检测450例吸毒人员和100例普通人员的血清丙肝病毒抗体(抗-HCV)。结果吸毒组血清丙肝抗体阳性301例,感染率为66.89%;对照组100例血清丙肝抗体阳性1例,感染率为1%,吸毒人群丙肝感染率是普通人群的66.89倍。结论吸毒是丙型肝炎的主要传播方式,对其实行抗-HCV筛检显得尤为重要,同时有关部门应进一步加强吸毒人员管理,防止丙肝在人群之间的传播。objective To understand the current infectious situation of hepatitis C （HCV） among drug users in Huizhou and determine the prevalence, influencing factors of hepatitis C, to provide scientific basis for the controlling of the dissemination of hepatitis C. Methods Enzyme linked immunosorbent assay （ELISA） were applied to detect serum anti-HCV in drug users and ordinary population in Huizhou. Results 301 are positive in the drug users group with the infectious rate of 66.89%; 1 of 100 are positive in the control group with the infectious rate of 1%. The HCV infectious rate among drug users is 66.89 times higher than that among the ordinary population. Conclusion Venous drug taking are the main infection ways. It plays an important role to availably grasp the situation of HCV infection by detecting serum anti-HCV in drug users. And ministries should strengthen the management of drug users to prevent the dissemination of hepatitis C from them.

关 键 词：丙型肝炎病毒 吸毒人群:抗-HCV 酶联免疫吸附实验 

分 类 号：R512.63[医药卫生—内科学]